These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27181297)

  • 1. Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials.
    Fan Y; Jiang M; Gong D; Zou C
    Sci Rep; 2016 May; 6():25984. PubMed ID: 27181297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of low-molecular-weight heparin on adult sepsis: a meta-analysis.
    Li X; Liu Z; Luo M; Xi Y; Li C; Wang S; Yang R
    Ann Palliat Med; 2021 Mar; 10(3):3115-3127. PubMed ID: 33849098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of low-molecular-weight heparin use for cancer treatment: a meta-analysis.
    Che DH; Cao JY; Shang LH; Man YC; Yu Y
    Eur J Intern Med; 2013 Jul; 24(5):433-9. PubMed ID: 23385011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
    Yang M; Xu Y; Chen H; Xu Z; Luo F
    Inflammopharmacology; 2020 Apr; 28(2):451-462. PubMed ID: 31673891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis.
    Kodumuri V; Adigopula S; Singh P; Swaminathan P; Arora R; Khosla S
    Am J Ther; 2011 May; 18(3):180-9. PubMed ID: 20027109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis.
    Zarychanski R; Abou-Setta AM; Kanji S; Turgeon AF; Kumar A; Houston DS; Rimmer E; Houston BL; McIntyre L; Fox-Robichaud AE; Hébert P; Cook DJ; Fergusson DA;
    Crit Care Med; 2015 Mar; 43(3):511-8. PubMed ID: 25493972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.
    Palmer AJ; Koppenhagen K; Kirchhof B; Weber U; Bergemann R
    Haemostasis; 1997; 27(2):75-84. PubMed ID: 9212355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
    Dumaine R; Borentain M; Bertel O; Bode C; Gallo R; White HD; Collet JP; Steinhubl SR; Montalescot G
    Arch Intern Med; 2007 Dec; 167(22):2423-30. PubMed ID: 18071163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Small dose of low molecular weight heparin improves the prognosis of elderly patients with severe pneumonia: a Meta-analysis of 1 173 patients].
    Yang H; Qian H; Shen F; Liu B; Wu Y; Cheng Y; Yang G; Li X; Zheng X; Qin J; Li S; He T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):26-32. PubMed ID: 32148227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
    Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
    Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials.
    Lim W; Cook DJ; Crowther MA
    J Am Soc Nephrol; 2004 Dec; 15(12):3192-206. PubMed ID: 15579523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?
    Schulman S
    Haemostasis; 1998; 28 Suppl 3():17-21. PubMed ID: 10069758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandalà M; Papaldo P; Fabi A; Ciccarese M; Cuppone F; Cecere FL; Nuzzo C; Terzoli E; Cognetti F
    Chest; 2006 Dec; 130(6):1808-16. PubMed ID: 17167001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
    Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
    Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients: A Systematic Review and Meta-Analysis.
    Montroy J; Lalu MM; Auer RC; Grigor E; Mazzarello S; Carrier M; Kimmelman J; Fergusson DA
    Thromb Haemost; 2020 May; 120(5):832-846. PubMed ID: 32369854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
    Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
    J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparins: are they interchangeable?
    van der Heijden JF; Prins MH; Büller HR
    Haemostasis; 2000; 30 Suppl 2():148-57; discussion 146-7. PubMed ID: 11251361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis.
    Sirico A; Saccone G; Maruotti GM; Grandone E; Sarno L; Berghella V; Zullo F; Martinelli P
    J Matern Fetal Neonatal Med; 2019 Jun; 32(11):1893-1900. PubMed ID: 29251025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.